[1]
A. B. Shah, P. P. Yadav, M. A. Chaudhari, J. Rai, and N. D. Kantharia, “Bipolar disorder: a review of current U.S. Food and Drug Administration approved pharmacotherapy”, Int J Basic Clin Pharmacol, vol. 4, no. 4, pp. 623–631, Jan. 2017.